drugset / Trial / NCT02974114

Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain

NCT02974114

Phase 4 Terminated 21 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindOther

Summary

This parallel, assessor blind, placebo-controlled, stratified, randomized study will investigate the effects of everyday pain on cognition and mobility in otherwise healthy individuals.

Timeline

Start
2016-10-31
Primary completion
2017-02-06
Completion
2017-02-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg Oral
Subject Caffeine Small molecule 65 mg Oral

Indications

No indication recorded.